Access practical guides, ROI calculators, and success stories designed to help you benchmark and improve your revenue cycle.
HealthCell provides billing for HIV/AIDS management, hepatitis treatment, complex antibiotic infusion therapy, travel medicine, immunocompromised patient care, and consultative ID services. Our team handles both office-based and hospital consult billing. We also manage billing for emerging infectious disease services including post-COVID care programs and long-term management of complex multi-drug resistant infections.
We handle billing for outpatient IV antibiotic therapy (OPAT), antifungal infusions, and other complex drug regimens—including HCPCS drug codes, administration codes, and pump supplies. HealthCell ensures all components of infusion care are captured and billed correctly. Our team also coordinates with home infusion vendors when applicable to ensure seamless billing across the continuum of outpatient infusion care.
Yes. We manage prior authorizations for HIV antiretroviral regimens, hepatitis C direct-acting antivirals, and specialty anti-infectives. Our team tracks approvals and works proactively with payers to prevent treatment delays. We also manage patient assistance program coordination for high-cost ID medications where insurance coverage is limited or denied.
Absolutely. HealthCell bills for inpatient and outpatient ID consultations, including initial consult codes and subsequent visit management. We ensure documentation supports the level of service billed and that your providers are correctly enrolled across all facilities. Our team manages credentialing at multiple hospital systems simultaneously so your ID physicians can consult without billing disruption.
Infectious disease billing often involves high-cost medications, long-term patient management, complex drug assistance program coordination, and dual billing in both office and hospital settings. HealthCell’s experienced team manages these complexities to ensure your practice is paid fully and on time. We also help ID practices navigate the financial and compliance aspects of participation in 340B drug pricing programs.
The trusted financial backbone for independent practices—stable collections, fewer denials, and freedom to focus on care.
